EMC1
protein-codingER membrane protein complex subunit 1, the group of ER membrane protein complex subunits
Gene summary
This gene encodes a single-pass type I transmembrane protein, which is a subunit of the endoplasmic reticulum membrane protein complex (EMC). Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2012]
- KIAA0090
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~35.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0014811
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0014811
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0014811
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0018822
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0014811
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0100516
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0100516
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0100516
Submitter: ClinGen
EMC1 is a component of the EMC complex, a multifunctional, multi-subunit protein complex involved in insertion of trans-membrane domains with low hydrophobicity into the ER membrane. *EMC1* was first reported in relation to autosomal dominant complex neurodevelopmental disorder with motor features in 2016 (Harel et al., PMID 26942288). *EMC1* has been noted to be associated with the following disease entities: Cerebellar atrophy, visual impairment, and psychomotor retardation (MIM:616875) and Global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndrome (ORPHA:480898). Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found a difference in inheritance pattern. The split curation for autosomal recessive complex neurodevelopmental disorder with motor features has been curated separately. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Summary of Case Level Data: 4 POINTS. 4 unique variants (all missense variants) that have been reported in 4 probands in 2 publications (PMIDs: 26942288, 35234901) are included in this curation. Structural modelling suggests that these variants cluster within the beta-propeller domain of the EMC1 protein (PMID: 35234901). For 3/4 of these variants, additional functional evidence is provided by failure of the mutant proteins to rescue phenotypes in a Drosophila model. This gene-disease association is also further supported by this Drosophila model, where knockdown in glia resulted in reduced viability and a motor phenotype which were rescued by expression of human wildtype *EMC1* (PMID: 35234901). In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Cerebral Palsy GCEP on the meeting date 6th October 2022 (SOP Version 9).
Inheritance Pattern: AR
Disease ID:MONDO:0100516
Submitter: ClinGen
EMC1 is a component of the EMC complex, a multifunctional, multi-subunit protein complex involved in insertion of trans-membrane domains with low hydrophobicity into the ER membrane. *EMC1* was first reported in relation to autosomal recessive complex neurodevelopmental disorder with motor features in 2016 (Harel et al., PMID 26942288). *EMC1* has been noted to be associated with the following disease entities: Cerebellar atrophy, visual impairment, and psychomotor retardation (MIM:616875) and Global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndrome (ORPHA:480898). Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found a difference in inheritance pattern in some reported cases. The split curation for autosomal dominant complex neurodevelopmental disorder with motor features has been curated separately. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Summary of Case Level Data: 8 POINTS. 6 unique variants (including 3 missense, 1 nonsense, 1 frameshift, and 1 splicing) that have been reported in 5 probands in 3 publications (PMIDs: 26942288, 29271071, 32092440) are included in this curation. This gene-disease association is also supported by a Drosophila model, where knockdown in glia resulted in reduced viability and a motor phenotype which were rescued by expression of human *EMC1* (PMID: 35234901). In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Cerebral Palsy GCEP on the meeting date 3rd November 2022 (SOP Version 9).
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Neurologic; Ophthalmologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to EMC1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_015047.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 17 | 283 | 3 | 304 | |
| missense | 1 | 9 | 671 | 26 | 2 | 709 |
| nonsense | 15 | 14 | 4 | 33 | ||
| start loss | 1 | 2 | 3 | |||
| frameshift | 24 | 14 | 7 | 45 | ||
| splice donor/acceptor (+/-2bp) | 33 | 11 | 44 | |||
| Total | 41 | 73 | 710 | 309 | 5 | 1138 |
Highest pathogenic variant AF is 0.00014002305
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_055862.1 | 23 | MANE Select | |
| Ensembl | ENSP00000420608.1 | 23 | MANE Select | |
| RefSeq | NP_001258356.1 | 23 | Standard | |
| RefSeq | NP_001258357.1 | 23 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- protein folding in endoplasmic reticulum
Cellular Component
- integral component of membrane
- protein-containing complex
- ER membrane protein complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000477853
- Coding exons
- 23
- Length
- 35889
- Individuals with no LoFs
- 125582
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 166
- Defined
- 125748
- p
- 0.000660
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.35 | 493 | 585 | 0.843 | 0.0000345 | 6421 |
| Missense (PolyPhen) | 150 | 197.13 | 0.76093 | 2068 | ||
| Synonymous | 1.54 | 205 | 235 | 0.872 | 0.0000137 | 2037 |
| Loss of Function | 1.49 | 46 | 58.3 | 0.789 | 0.00000314 | 599 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00055 | 0.00055 | rare |
| Latino/Admixed American | 0.00087 | 0.00087 | rare |
| Ashkenazi Jewish | 0.00020 | 0.00020 | rare |
| East Asian | 0.00065 | 0.00065 | rare |
| Finnish | 0.00014 | 0.00014 | rare |
| European (Non-Finnish) | 0.00067 | 0.00067 | rare |
| South Asian | 0.00098 | 0.00098 | rare |
| Other | 0.00065 | 0.00065 | rare |
dbNSFP Gene Annotations
Source:
- Disease
- DISEASE: Cerebellar atrophy, visual impairment, and psychomotor retardation (CAVIPMR) [MIM:616875]: An autosomal recessive, neurodegenerative disorder characterized by developmental delay, intellectual disability, hypotonia, scoliosis, cerebellar atrophy, and variable dysmorphic features. {ECO:0000269|PubMed:26942288}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.113
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- E
- Essential (gene trap)
- K
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |